Lavage and Its Histopathologic Basis: A Cautionary Tale

Diagnostic Cytopathology

Volumn 30, Issue 3, 2004, Pages 166-171

  Badve, Sunil ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION BIOPSY; BREAST CANCER; BREAST DUCT; BREAST DUCTAL LAVAGE; CANCER RISK; CANCER SCREENING; CONFERENCE PAPER; CYTODIAGNOSIS; CYTOPATHOLOGY; FEMALE; GAIL MODEL; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LAVAGE; MOLECULAR BIOLOGY; NIPPLE; NIPPLE ASPIRATION FLUID; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; BREAST TUMOR; CONTROLLED CLINICAL TRIAL; CYTOLOGY; DIAGNOSTIC ERROR; MAMMARY GLAND; MASS SCREENING; METHODOLOGY; REVIEW; SECRETION; STANDARD;

BREAST NEOPLASMS; CONTROLLED CLINICAL TRIALS; CYTODIAGNOSIS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IRRIGATION; MAMMARY GLANDS, HUMAN; MASS SCREENING; NIPPLES;

EID: 1542366317     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.20001     Document Type: Conference Paper

References (50)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Papanicolaou G, Holmquist D, Bader G, Falk E. Exfoliative cytology of human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer 1958;11:377-409.
3. Petrakis NL, Ernster VL, King EB, Sacks ST. Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors. J Natl Cancer Inst 1982;68:9-13.
4. Wrensch MR, Petrakis NL, Gruenke LD, et al. Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat 1990;15:39-51.
5. Wrensch M, Petrakis NL, King EB, Lee MM, Miike R. Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy. Am J Epidemiol 1993;137:829-833.
6. Medina D. Preneoplastic lesions in murine mammary cancer. Cancer Res 1976;36:2589-2595.
7. Stratton MR, Collins N, Lakhani SR, Sloane JP. Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 1995;175:195-201.
8. Lakhani SR, Collins N, Stratton MR, Sloane JP. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 1995;48:611-615.
9. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996;274:2057-2059.
10. Lakhani SR. The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 1999;187:272-278.
11. Cornelio DA, Schmid-Braz AT, Cavalli LR, Lima RS, Ribeiro EM, Cavalli IJ. Clonal karyotypic abnormalities in gynecomastia. Cancer Genet Cytogenet 1999;115:128-133.
12. Lakhani SR, Chaggar R, Davies S, et al. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J Pathol 1999;189:496-503.
13. Li Z, Moore DH, Meng ZH, Ljung BM, Gray JW, Dairkee SH. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients. Cancer Res 2002;62:1000-1003.
14. Boecker W, Buerger H, Schmitz K, et al. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression pattems. J Pathol 2001;195:415-421.
15. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985;55:2698-2708.
16. Badve S, Wiley E, Rodriguez N. Assessment of utility of ductal lavage and ductoscopy in breast cancer-a retrospective analysis of mastectomy specimens. Mod Pathol 2003;16:206-209.
17. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 1975;36:1-85.
18. Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 2001;93:1791-1798.
19. Wiley E. Histology of intraductal lesions-correlation and sampling issues. Presented at the Lynn Sage Breast Cancer Symposium, Chicago; 2003.
20. Khan S, Rodriguez N, Baird C. Ductal lavage findings in women with known breast cancer undergoing mastectomy. Breast Cancer Res Treat 2003;76:S35.
21. Dooley WC, Ljung BM, Veronesi U, et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 2001;93:1624-1632.
22. Sartorius O, Morris P, Benedict D. Contrast ductography for recognition and localization of benign and malignant breast lesions: an improved technique. In: Logan W, editor. Breast carcinoma. New York: John Wiley & Sons; 1977. p 281-300.
23. Gray H, Bannister L, Berry M, Williams P. Mammary glands - splanchnology. In: Bannister L, editor. Gray's anatomy: the anatomical basis of medicine & surgery. London: University of London; 1995.
24. Ohtake T, Kimijima I, Fukushima T, et al. Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: implications of ductal anastomoses for breast-conserving surgery. Cancer 2001;91:2263-2272.
25. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975;55:231-273.
26. Wellings S. A hypothesis of the origin of human breast cancer from terminal ductal lobular unit. Pathol Res Pract 1980;166:515-535.
27. Khan SA, Baird C, Staradub VL, Morrow M. Ductal lavage and ductoscopy: the opportunities and the limitations. Clin Breast Cancer 2002;3:185-191; discussion 192-185.
28. Golshan M, Khan SA. Role of breast epithelial sampling techniques in high-risk women. In: Morrow M, Jordan V, editors. Managing breast cancer risk. London: BC Decker; 2003. p 139-156.
29. Dooley WC, Veronesi U, Elledge R, O'Shaughnessy J, Ljung B, Arias R. Detection of premalignant and malignant breast cells by ductal lavage. Obstet Gynecol 2001;97:S2.
30. Wrensch MR, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1992;135:130-141.
31. Layfield LJ, Glasgow BJ, Cramer H. Fine-needle aspiration in the management of breast masses. Pathol Annu 1989;24(Pt 2):23-62.
32. Wollenberg NJ, Caya JG, Clowry LJ. Fine needle aspiration cytology of the breast. A review of 321 cases with statistical evaluation. Acta Cytol 1985;29:425-429.
33. Zajdela A, Ghossein NA, Pilleron JP, Ennuyer A. The value of aspiration cytology in the diagnosis of breast cancer: experience at the Fondation Curie. Cancer 1975;35:499-506.
34. The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees. Diagn Cytopathol 1997;16:295-311.
35. Ward JH, Marshall CJ, Schumann GB, et al. Detection of proliferative breast disease by four-quadrant, fine-needle aspiration. J Natl Cancer Inst 1990;82:964-966.
36. Skolnick MH, Cannon-Albright LA, Goldgar DE, et al. Inheritance of proliferative breast disease in breast cancer kindreds. Science 1990;250:1715-1720.
37. Fabian CJ, Kamel S, Zalles C, Kimler BF. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer. J Cell Biochem Suppl 1996;25:112-122.
38. Fabian CJ, Zalles C, Kamel S, et al. Biomarker and cytologic abnormalities in women at high and low risk for breast cancer. J Cell Biochem Suppl 1993;17G:153-160.
39. Nayar R, Khurana K, Yang Y, Nicolas M, Barbescu E, Khan SA. Atypia on breast fine needle aspiration (FNA): is it a reliable criterion for breast cancer risk assessment? Lab Invest 2002;82:44A.
40. Domchek SM. The utility of ductal lavage in breast cancer detection and risk assessment. Breast Cancer Res 2002;4:51-53.
41. Rabban T, Ljung B. Reproducibility in interpreting breast duct fluid cytology following standardized web-based training. Lab Invest 2002;82:85A.
42. Shen KW, Wu J, Lu JS, et al. Fiberoptic ductoscopy for breast cancer patients with nipple discharge. Surg Endosc 2001;15:1340-1345.
43. Lawler M, Newton A, Levin E, Mosher R. Cytologic evaluation of duct washings does not reliably detect lactiferous duct pathology. Breast Cancer Res 2001;69:297.
44. Masood S. The missing link: a "Pap smear" for early breast cancer detection and prevention. Breast J 1999;5:1-2.
45. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994;73:643-651.
46. Claus EB, Risch N, Thompson WD. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat 1993;28:115-120.
47. Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999;91:1541-1548.
48. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886.
49. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358-366.
50. Morrow M, Vogel V, Ljung BM, O'Shaughnessy JA. Evaluation and management of the woman with an abnormal ductal lavage. J Am Coll Surg 2002;194:648-656.